

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 4.99441553 |
| 2 | negative T cell selection (GO:0043383) | 4.95209902 |
| 3 | negative thymic T cell selection (GO:0045060) | 4.94540525 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.89230924 |
| 5 | positive thymic T cell selection (GO:0045059) | 4.85347545 |
| 6 | thymic T cell selection (GO:0045061) | 4.79504976 |
| 7 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.41825244 |
| 8 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.34328907 |
| 9 | positive T cell selection (GO:0043368) | 4.30943143 |
| 10 | formation of translation preinitiation complex (GO:0001731) | 4.26481115 |
| 11 | DNA unwinding involved in DNA replication (GO:0006268) | 4.18449745 |
| 12 | T cell selection (GO:0045058) | 4.14660596 |
| 13 | DNA strand elongation (GO:0022616) | 4.10532355 |
| 14 | DNA replication initiation (GO:0006270) | 4.08353221 |
| 15 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.06598426 |
| 16 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01249193 |
| 17 | histone H3-K4 trimethylation (GO:0080182) | 3.88589333 |
| 18 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.87962320 |
| 19 | negative regulation of cell killing (GO:0031342) | 3.87962320 |
| 20 | nucleobase biosynthetic process (GO:0046112) | 3.85021889 |
| 21 | maturation of SSU-rRNA (GO:0030490) | 3.82463814 |
| 22 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.74029758 |
| 23 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.71475701 |
| 24 | positive regulation of granulocyte differentiation (GO:0030854) | 3.71137311 |
| 25 | positive regulation of CREB transcription factor activity (GO:0032793) | 3.67752190 |
| 26 | ribosome assembly (GO:0042255) | 3.66883780 |
| 27 | telomere maintenance via recombination (GO:0000722) | 3.66308447 |
| 28 | protein localization to kinetochore (GO:0034501) | 3.62979516 |
| 29 | leukocyte aggregation (GO:0070486) | 3.49927410 |
| 30 | IMP biosynthetic process (GO:0006188) | 3.47388774 |
| 31 | mitotic nuclear envelope disassembly (GO:0007077) | 3.46983996 |
| 32 | ribosomal small subunit assembly (GO:0000028) | 3.46001042 |
| 33 | DNA deamination (GO:0045006) | 3.44727293 |
| 34 | ribosome biogenesis (GO:0042254) | 3.43977638 |
| 35 | DNA replication checkpoint (GO:0000076) | 3.41967194 |
| 36 | mitotic recombination (GO:0006312) | 3.38484508 |
| 37 | activated T cell proliferation (GO:0050798) | 3.38061562 |
| 38 | histone H3-K4 methylation (GO:0051568) | 3.36317880 |
| 39 | purine nucleobase biosynthetic process (GO:0009113) | 3.36202918 |
| 40 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.36039710 |
| 41 | histone H3-K36 demethylation (GO:0070544) | 3.34527272 |
| 42 | tolerance induction (GO:0002507) | 3.29885172 |
| 43 | mannose metabolic process (GO:0006013) | 3.28760311 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.26638405 |
| 45 | cellular response to interleukin-15 (GO:0071350) | 3.26503219 |
| 46 | response to interleukin-15 (GO:0070672) | 3.25885744 |
| 47 | regulation of histone H3-K27 methylation (GO:0061085) | 3.25190136 |
| 48 | membrane disassembly (GO:0030397) | 3.23354147 |
| 49 | nuclear envelope disassembly (GO:0051081) | 3.23354147 |
| 50 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 3.22779326 |
| 51 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.21706665 |
| 52 | B cell receptor signaling pathway (GO:0050853) | 3.21449691 |
| 53 | natural killer cell differentiation (GO:0001779) | 3.18924208 |
| 54 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.18042227 |
| 55 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.18042227 |
| 56 | positive regulation of histone deacetylation (GO:0031065) | 3.17460128 |
| 57 | mitotic metaphase plate congression (GO:0007080) | 3.16650795 |
| 58 | positive regulation by host of viral transcription (GO:0043923) | 3.16499620 |
| 59 | telomere maintenance via telomere lengthening (GO:0010833) | 3.15038015 |
| 60 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.14931987 |
| 61 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.14580350 |
| 62 | IMP metabolic process (GO:0046040) | 3.14073350 |
| 63 | histone H3-K9 modification (GO:0061647) | 3.13529931 |
| 64 | Peyers patch development (GO:0048541) | 3.13300218 |
| 65 | mucosal-associated lymphoid tissue development (GO:0048537) | 3.13300218 |
| 66 | intracellular estrogen receptor signaling pathway (GO:0030520) | 3.12739433 |
| 67 | regulation of histone H3-K4 methylation (GO:0051569) | 3.12452044 |
| 68 | viral transcription (GO:0019083) | 3.11298766 |
| 69 | ribosomal large subunit biogenesis (GO:0042273) | 3.11181521 |
| 70 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 3.09610906 |
| 71 | translational termination (GO:0006415) | 3.08779782 |
| 72 | histone H3-K9 methylation (GO:0051567) | 3.06221014 |
| 73 | translational initiation (GO:0006413) | 3.03830817 |
| 74 | regulation of granulocyte differentiation (GO:0030852) | 3.03155765 |
| 75 | nuclear pore organization (GO:0006999) | 3.01842725 |
| 76 | modulation by virus of host process (GO:0019054) | 3.00994563 |
| 77 | protein localization to chromosome, centromeric region (GO:0071459) | 3.00138152 |
| 78 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.99781495 |
| 79 | rRNA processing (GO:0006364) | 2.99686599 |
| 80 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.95831741 |
| 81 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.94223345 |
| 82 | translational elongation (GO:0006414) | 2.92637592 |
| 83 | cellular response to virus (GO:0098586) | 2.92581034 |
| 84 | negative regulation of histone methylation (GO:0031061) | 2.92361307 |
| 85 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.92345796 |
| 86 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.91843342 |
| 87 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.90491636 |
| 88 | B cell mediated immunity (GO:0019724) | 2.89797703 |
| 89 | rRNA metabolic process (GO:0016072) | 2.87916500 |
| 90 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.87484160 |
| 91 | spliceosomal snRNP assembly (GO:0000387) | 2.87381521 |
| 92 | immunoglobulin mediated immune response (GO:0016064) | 2.85152360 |
| 93 | tRNA methylation (GO:0030488) | 2.84921630 |
| 94 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.84534992 |
| 95 | regulation of translational termination (GO:0006449) | 2.84152477 |
| 96 | peptidyl-lysine methylation (GO:0018022) | 2.81582097 |
| 97 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.79920421 |
| 98 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.79920421 |
| 99 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.79901165 |
| 100 | positive regulation of protein deacetylation (GO:0090312) | 2.79726352 |
| 101 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.78904696 |
| 102 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.75757584 |
| 103 | ribosomal small subunit biogenesis (GO:0042274) | 2.73103318 |
| 104 | peptidyl-lysine trimethylation (GO:0018023) | 2.72891616 |
| 105 | histone H3 deacetylation (GO:0070932) | 2.72888446 |
| 106 | DNA duplex unwinding (GO:0032508) | 2.72817410 |
| 107 | cellular response to interleukin-4 (GO:0071353) | 2.72236204 |
| 108 | histone lysine methylation (GO:0034968) | 2.72090770 |
| 109 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.71986574 |
| 110 | DNA geometric change (GO:0032392) | 2.71686642 |
| 111 | histone H4 deacetylation (GO:0070933) | 2.71197130 |
| 112 | snRNA metabolic process (GO:0016073) | 2.71168904 |
| 113 | positive regulation of gene expression, epigenetic (GO:0045815) | 2.71131918 |
| 114 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.71072399 |
| 115 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.70452928 |
| 116 | cell cycle G1/S phase transition (GO:0044843) | 2.69449425 |
| 117 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.69449425 |
| 118 | tRNA modification (GO:0006400) | 2.67625502 |
| 119 | regulation of protein heterodimerization activity (GO:0043497) | 2.67289579 |
| 120 | chromatin silencing (GO:0006342) | 2.66922685 |
| 121 | folic acid metabolic process (GO:0046655) | 2.65860263 |
| 122 | histone H4-K16 acetylation (GO:0043984) | 2.63742289 |
| 123 | histone methylation (GO:0016571) | 2.63548394 |
| 124 | base-excision repair (GO:0006284) | 2.63332459 |
| 125 | metaphase plate congression (GO:0051310) | 2.62693133 |
| 126 | nuclear pore complex assembly (GO:0051292) | 2.62454580 |
| 127 | regulation of histone methylation (GO:0031060) | 2.62259295 |
| 128 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.61746989 |
| 129 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.60717381 |
| 130 | negative regulation of ligase activity (GO:0051352) | 2.60717381 |
| 131 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.60371946 |
| 132 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.59922489 |
| 133 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.59922489 |
| 134 | DNA methylation (GO:0006306) | 2.59887099 |
| 135 | DNA alkylation (GO:0006305) | 2.59887099 |
| 136 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.58441631 |
| 137 | negative regulation of gene expression, epigenetic (GO:0045814) | 2.58284356 |
| 138 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.57968841 |
| 139 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.57968841 |
| 140 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.57968841 |
| 141 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 2.57670899 |
| 142 | regulation of B cell differentiation (GO:0045577) | 2.57663195 |
| 143 | nuclear envelope organization (GO:0006998) | 2.56977393 |
| 144 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.56542312 |
| 145 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.56542312 |
| 146 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.56540364 |
| 147 | interferon-gamma production (GO:0032609) | 2.56460449 |
| 148 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.54681218 |
| 149 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.54273115 |
| 150 | establishment of chromosome localization (GO:0051303) | 2.54252923 |
| 151 | viral mRNA export from host cell nucleus (GO:0046784) | 2.54193583 |
| 152 | mitotic sister chromatid segregation (GO:0000070) | 2.53640691 |
| 153 | regulation of gene silencing by RNA (GO:0060966) | 2.52609148 |
| 154 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.52609148 |
| 155 | regulation of gene silencing by miRNA (GO:0060964) | 2.52609148 |
| 156 | negative regulation of T cell mediated immunity (GO:0002710) | 2.52332184 |
| 157 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.51843004 |
| 158 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.51820865 |
| 159 | ncRNA 3-end processing (GO:0043628) | 2.51730092 |
| 160 | snRNA processing (GO:0016180) | 2.50781270 |
| 161 | regulation of double-strand break repair via homologous recombination (GO:0010569) | 2.50464749 |
| 162 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.50022755 |
| 163 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.49620438 |
| 164 | NIK/NF-kappaB signaling (GO:0038061) | 2.49081082 |
| 165 | chromatin remodeling at centromere (GO:0031055) | 2.47881915 |
| 166 | CENP-A containing nucleosome assembly (GO:0034080) | 2.47487663 |
| 167 | pseudouridine synthesis (GO:0001522) | 2.47233330 |
| 168 | viral life cycle (GO:0019058) | 2.46845553 |
| 169 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.46446194 |
| 170 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.46143053 |
| 171 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.46019357 |
| 172 | negative regulation of histone acetylation (GO:0035067) | 2.45207353 |
| 173 | regulation of translational fidelity (GO:0006450) | 2.44967281 |
| 174 | telomere organization (GO:0032200) | 2.44944583 |
| 175 | protein targeting to ER (GO:0045047) | 2.44866090 |
| 176 | regulation of spindle organization (GO:0090224) | 2.44123290 |
| 177 | DNA topological change (GO:0006265) | 2.43905887 |
| 178 | telomere maintenance (GO:0000723) | 2.43867859 |
| 179 | regulation of translation in response to stress (GO:0043555) | 2.43839065 |
| 180 | cotranslational protein targeting to membrane (GO:0006613) | 2.43722513 |
| 181 | cellular protein complex disassembly (GO:0043624) | 2.43708548 |
| 182 | regulation of histone deacetylation (GO:0031063) | 2.42250112 |
| 183 | negative regulation of innate immune response (GO:0045824) | 2.42018338 |
| 184 | negative regulation of mRNA processing (GO:0050686) | 2.41537301 |
| 185 | meiotic chromosome segregation (GO:0045132) | 2.40726596 |
| 186 | GDP-mannose metabolic process (GO:0019673) | 2.40630716 |
| 187 | mast cell degranulation (GO:0043303) | 2.39935027 |
| 188 | mast cell activation involved in immune response (GO:0002279) | 2.39935027 |
| 189 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.39784172 |
| 190 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.39784172 |
| 191 | chromatin assembly (GO:0031497) | 2.39748197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.59106907 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.74689682 |
| 3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.66583406 |
| 4 | * FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.19564399 |
| 5 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.76252401 |
| 6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.75258467 |
| 7 | * MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.69983526 |
| 8 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.50301784 |
| 9 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.43512840 |
| 10 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.43249303 |
| 11 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.40641880 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.35868455 |
| 13 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.32609022 |
| 14 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.30033094 |
| 15 | * GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.29207885 |
| 16 | P68_20966046_ChIP-Seq_HELA_Human | 2.25029908 |
| 17 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.23785720 |
| 18 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.22681949 |
| 19 | MAF_26560356_Chip-Seq_TH2_Human | 2.22167341 |
| 20 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.21296990 |
| 21 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.17294226 |
| 22 | * MYC_22102868_ChIP-Seq_BL_Human | 2.13800079 |
| 23 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10187964 |
| 24 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.05655709 |
| 25 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.05568726 |
| 26 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 2.04226135 |
| 27 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.02379164 |
| 28 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.00186410 |
| 29 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.94770664 |
| 30 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.94479099 |
| 31 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.92345283 |
| 32 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.90584423 |
| 33 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.89974959 |
| 34 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.78411767 |
| 35 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.78247634 |
| 36 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.78086923 |
| 37 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.76911099 |
| 38 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.75994616 |
| 39 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.74541012 |
| 40 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.73212404 |
| 41 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.70168271 |
| 42 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.68923428 |
| 43 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67177167 |
| 44 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.64834114 |
| 45 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.64648066 |
| 46 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.64326255 |
| 47 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.63880493 |
| 48 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.62713277 |
| 49 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.62193987 |
| 50 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.60362933 |
| 51 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.60309333 |
| 52 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.59750135 |
| 53 | * PHF8_20622854_ChIP-Seq_HELA_Human | 1.58596444 |
| 54 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.58340667 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55801925 |
| 56 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.53559577 |
| 57 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.52663996 |
| 58 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.52234461 |
| 59 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.52076357 |
| 60 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.51024185 |
| 61 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50730191 |
| 62 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49304513 |
| 63 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.49068783 |
| 64 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.47615434 |
| 65 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47260694 |
| 66 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.44820725 |
| 67 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.44749275 |
| 68 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43705274 |
| 69 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.43521287 |
| 70 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.43205000 |
| 71 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.43031593 |
| 72 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.41560218 |
| 73 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.40671510 |
| 74 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.40402677 |
| 75 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.38990618 |
| 76 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.38966685 |
| 77 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.38898422 |
| 78 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.37256257 |
| 79 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.37222199 |
| 80 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.35851252 |
| 81 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.35842628 |
| 82 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.34610662 |
| 83 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.33929819 |
| 84 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.33346218 |
| 85 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.31889705 |
| 86 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.31022556 |
| 87 | * PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30889569 |
| 88 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.28701408 |
| 89 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.27335768 |
| 90 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.27334491 |
| 91 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.27153365 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.26867981 |
| 93 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.26429329 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.26403810 |
| 95 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.26284887 |
| 96 | P300_27268052_Chip-Seq_Bcells_Human | 1.23424651 |
| 97 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.23337707 |
| 98 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.22301958 |
| 99 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.22094582 |
| 100 | * FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.22048142 |
| 101 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.22036310 |
| 102 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.21049843 |
| 103 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.20830159 |
| 104 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.20721510 |
| 105 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.20703843 |
| 106 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.20406354 |
| 107 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20240401 |
| 108 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19479770 |
| 109 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.19316858 |
| 110 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.18950561 |
| 111 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.18848865 |
| 112 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.17548568 |
| 113 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.17413094 |
| 114 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.17258892 |
| 115 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.17227894 |
| 116 | * TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 1.15802960 |
| 117 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.15723841 |
| 118 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.15604929 |
| 119 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.15497771 |
| 120 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.14786606 |
| 121 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.13934421 |
| 122 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.13853419 |
| 123 | ERA_21632823_ChIP-Seq_H3396_Human | 1.12856681 |
| 124 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.12663283 |
| 125 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.12155543 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.12054543 |
| 127 | SA1_27219007_Chip-Seq_Bcells_Human | 1.11792311 |
| 128 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.11408606 |
| 129 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.11295729 |
| 130 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.10550122 |
| 131 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09579314 |
| 132 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09113898 |
| 133 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.08937747 |
| 134 | * OCT4_19829295_ChIP-Seq_ESCs_Human | 1.08773368 |
| 135 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.08143092 |
| 136 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.08110159 |
| 137 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.07009028 |
| 138 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.04293705 |
| 139 | MAF_26560356_Chip-Seq_TH1_Human | 1.02644876 |
| 140 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.02221753 |
| 141 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.02144924 |
| 142 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.02094226 |
| 143 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.99848920 |
| 144 | UTX_26944678_Chip-Seq_JUKART_Human | 0.99084995 |
| 145 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.98551428 |
| 146 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.93837708 |
| 147 | MYB_26560356_Chip-Seq_TH1_Human | 0.93537263 |
| 148 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 0.92863881 |
| 149 | * MYB_26560356_Chip-Seq_TH2_Human | 0.92213167 |
| 150 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.91868967 |
| 151 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.91501898 |
| 152 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.90849178 |
| 153 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.90164799 |
| 154 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.90019338 |
| 155 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.89186880 |
| 156 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.89110055 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003693_abnormal_embryo_hatching | 4.42378595 |
| 2 | MP0003111_abnormal_nucleus_morphology | 3.39070006 |
| 3 | MP0004957_abnormal_blastocyst_morpholog | 3.34179872 |
| 4 | MP0010094_abnormal_chromosome_stability | 3.29668581 |
| 5 | MP0003077_abnormal_cell_cycle | 3.10855286 |
| 6 | MP0008057_abnormal_DNA_replication | 2.81464707 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.75352987 |
| 8 | MP0010352_gastrointestinal_tract_polyps | 2.70219526 |
| 9 | MP0003436_decreased_susceptibility_to | 2.68989911 |
| 10 | MP0008058_abnormal_DNA_repair | 2.26035318 |
| 11 | MP0004381_abnormal_hair_follicle | 2.14853158 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.11131274 |
| 13 | MP0005451_abnormal_body_composition | 2.01521948 |
| 14 | MP0010307_abnormal_tumor_latency | 1.99560336 |
| 15 | MP0003303_peritoneal_inflammation | 1.96785489 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 1.95805211 |
| 17 | MP0009785_altered_susceptibility_to | 1.94232955 |
| 18 | MP0008007_abnormal_cellular_replicative | 1.88132271 |
| 19 | MP0008932_abnormal_embryonic_tissue | 1.87462816 |
| 20 | MP0002452_abnormal_antigen_presenting | 1.87451884 |
| 21 | MP0000350_abnormal_cell_proliferation | 1.86977251 |
| 22 | MP0000490_abnormal_crypts_of | 1.86831829 |
| 23 | MP0005000_abnormal_immune_tolerance | 1.86706259 |
| 24 | MP0005076_abnormal_cell_differentiation | 1.86311848 |
| 25 | MP0000685_abnormal_immune_system | 1.86287778 |
| 26 | MP0005025_abnormal_response_to | 1.83745764 |
| 27 | MP0001730_embryonic_growth_arrest | 1.83599998 |
| 28 | MP0001800_abnormal_humoral_immune | 1.80172090 |
| 29 | MP0002419_abnormal_innate_immunity | 1.77587118 |
| 30 | MP0001853_heart_inflammation | 1.74181192 |
| 31 | MP0003806_abnormal_nucleotide_metabolis | 1.74080267 |
| 32 | MP0002405_respiratory_system_inflammati | 1.73849780 |
| 33 | MP0002723_abnormal_immune_serum | 1.72480630 |
| 34 | MP0002148_abnormal_hypersensitivity_rea | 1.70757719 |
| 35 | MP0002398_abnormal_bone_marrow | 1.69791250 |
| 36 | MP0001348_abnormal_lacrimal_gland | 1.68107450 |
| 37 | MP0002420_abnormal_adaptive_immunity | 1.67259733 |
| 38 | MP0001819_abnormal_immune_cell | 1.67249684 |
| 39 | MP0000858_altered_metastatic_potential | 1.60145790 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.56445492 |
| 41 | MP0002019_abnormal_tumor_incidence | 1.54135915 |
| 42 | MP0002722_abnormal_immune_system | 1.53800476 |
| 43 | MP0003763_abnormal_thymus_physiology | 1.53229747 |
| 44 | MP0008995_early_reproductive_senescence | 1.52225044 |
| 45 | MP0005671_abnormal_response_to | 1.52065829 |
| 46 | MP0001545_abnormal_hematopoietic_system | 1.50706062 |
| 47 | MP0005397_hematopoietic_system_phenotyp | 1.50706062 |
| 48 | MP0003866_abnormal_defecation | 1.48570291 |
| 49 | MP0005310_abnormal_salivary_gland | 1.48204671 |
| 50 | MP0000716_abnormal_immune_system | 1.48048821 |
| 51 | MP0009840_abnormal_foam_cell | 1.45881863 |
| 52 | MP0008961_abnormal_basal_metabolism | 1.44470152 |
| 53 | MP0005075_abnormal_melanosome_morpholog | 1.43058334 |
| 54 | MP0002429_abnormal_blood_cell | 1.41920793 |
| 55 | MP0009278_abnormal_bone_marrow | 1.41681896 |
| 56 | MP0001790_abnormal_immune_system | 1.40627585 |
| 57 | MP0005387_immune_system_phenotype | 1.40627585 |
| 58 | MP0003787_abnormal_imprinting | 1.37798360 |
| 59 | MP0000313_abnormal_cell_death | 1.36553356 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.36110489 |
| 61 | MP0003448_altered_tumor_morphology | 1.34119945 |
| 62 | MP0002163_abnormal_gland_morphology | 1.33670368 |
| 63 | MP0003786_premature_aging | 1.33432133 |
| 64 | MP0005058_abnormal_lysosome_morphology | 1.31247941 |
| 65 | MP0003123_paternal_imprinting | 1.29392121 |
| 66 | MP0004808_abnormal_hematopoietic_stem | 1.28939908 |
| 67 | MP0003172_abnormal_lysosome_physiology | 1.28914483 |
| 68 | MP0000703_abnormal_thymus_morphology | 1.27574209 |
| 69 | MP0003191_abnormal_cellular_cholesterol | 1.26413520 |
| 70 | MP0005464_abnormal_platelet_physiology | 1.25353037 |
| 71 | MP0004185_abnormal_adipocyte_glucose | 1.24230289 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.23487018 |
| 73 | MP0001986_abnormal_taste_sensitivity | 1.23147161 |
| 74 | MP0004947_skin_inflammation | 1.22325574 |
| 75 | MP0002080_prenatal_lethality | 1.22243915 |
| 76 | MP0002653_abnormal_ependyma_morphology | 1.20382575 |
| 77 | MP0001697_abnormal_embryo_size | 1.19571742 |
| 78 | MP0003186_abnormal_redox_activity | 1.19217112 |
| 79 | MP0005377_hearing/vestibular/ear_phenot | 1.19210428 |
| 80 | MP0003878_abnormal_ear_physiology | 1.19210428 |
| 81 | MP0006082_CNS_inflammation | 1.16956730 |
| 82 | MP0001672_abnormal_embryogenesis/_devel | 1.16828128 |
| 83 | MP0005380_embryogenesis_phenotype | 1.16828128 |
| 84 | MP0004510_myositis | 1.16765419 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.14350582 |
| 86 | MP0003566_abnormal_cell_adhesion | 1.12052505 |
| 87 | MP0005083_abnormal_biliary_tract | 1.08561657 |
| 88 | MP0001873_stomach_inflammation | 1.08561116 |
| 89 | MP0003984_embryonic_growth_retardation | 1.07433348 |
| 90 | MP0000358_abnormal_cell_content/ | 1.07194264 |
| 91 | MP0008260_abnormal_autophagy | 1.05396410 |
| 92 | MP0002088_abnormal_embryonic_growth/wei | 1.03938471 |
| 93 | MP0005174_abnormal_tail_pigmentation | 1.03783154 |
| 94 | MP0005023_abnormal_wound_healing | 1.02949191 |
| 95 | MP0000371_diluted_coat_color | 1.02461095 |
| 96 | MP0001533_abnormal_skeleton_physiology | 1.01732670 |
| 97 | MP0004197_abnormal_fetal_growth/weight/ | 0.98900809 |
| 98 | MP0002086_abnormal_extraembryonic_tissu | 0.98608845 |
| 99 | MP0000470_abnormal_stomach_morphology | 0.98040340 |
| 100 | MP0006292_abnormal_olfactory_placode | 0.97566308 |
| 101 | MP0005645_abnormal_hypothalamus_physiol | 0.95957324 |
| 102 | MP0002970_abnormal_white_adipose | 0.94602793 |
| 103 | MP0002009_preneoplasia | 0.94370107 |
| 104 | MP0003724_increased_susceptibility_to | 0.94166808 |
| 105 | MP0002138_abnormal_hepatobiliary_system | 0.93543220 |
| 106 | MP0008469_abnormal_protein_level | 0.92853965 |
| 107 | MP0002132_abnormal_respiratory_system | 0.91436003 |
| 108 | MP0000015_abnormal_ear_pigmentation | 0.90777099 |
| 109 | MP0006035_abnormal_mitochondrial_morpho | 0.89601684 |
| 110 | MP0000465_gastrointestinal_hemorrhage | 0.88746131 |
| 111 | MP0002085_abnormal_embryonic_tissue | 0.88536839 |
| 112 | MP0002249_abnormal_larynx_morphology | 0.87643062 |
| 113 | MP0003453_abnormal_keratinocyte_physiol | 0.84850289 |
| 114 | MP0001663_abnormal_digestive_system | 0.84183772 |
| 115 | MP0005621_abnormal_cell_physiology | 0.83789004 |
| 116 | MP0002693_abnormal_pancreas_physiology | 0.82244281 |
| 117 | MP0003943_abnormal_hepatobiliary_system | 0.82126035 |
| 118 | MP0002084_abnormal_developmental_patter | 0.80394883 |
| 119 | MP0000343_altered_response_to | 0.80034971 |
| 120 | MP0005384_cellular_phenotype | 0.78547948 |
| 121 | MP0002254_reproductive_system_inflammat | 0.77670093 |
| 122 | MP0003718_maternal_effect | 0.76837259 |
| 123 | MP0004130_abnormal_muscle_cell | 0.76484612 |
| 124 | MP0000750_abnormal_muscle_regeneration | 0.76441246 |
| 125 | MP0002006_tumorigenesis | 0.76106106 |
| 126 | MP0008877_abnormal_DNA_methylation | 0.75983554 |
| 127 | MP0001929_abnormal_gametogenesis | 0.72588906 |
| 128 | MP0002928_abnormal_bile_duct | 0.72443143 |
| 129 | MP0003698_abnormal_male_reproductive | 0.72162708 |
| 130 | MP0002210_abnormal_sex_determination | 0.70931912 |
| 131 | MP0001293_anophthalmia | 0.70732690 |
| 132 | MP0002822_catalepsy | 0.69335166 |
| 133 | MP0005670_abnormal_white_adipose | 0.68517397 |
| 134 | MP0001346_abnormal_lacrimal_gland | 0.68371865 |
| 135 | MP0000678_abnormal_parathyroid_gland | 0.68349212 |
| 136 | MP0005266_abnormal_metabolism | 0.67875314 |
| 137 | MP0003136_yellow_coat_color | 0.67001087 |
| 138 | MP0000598_abnormal_liver_morphology | 0.65793062 |
| 139 | MP0003567_abnormal_fetal_cardiomyocyte | 0.65116039 |
| 140 | MP0002166_altered_tumor_susceptibility | 0.64924771 |
| 141 | MP0005410_abnormal_fertilization | 0.63385524 |
| 142 | MP0000477_abnormal_intestine_morphology | 0.63330763 |
| 143 | MP0005220_abnormal_exocrine_pancreas | 0.62734610 |
| 144 | MP0002933_joint_inflammation | 0.62527173 |
| 145 | MP0005379_endocrine/exocrine_gland_phen | 0.62110221 |
| 146 | MP0000367_abnormal_coat/_hair | 0.61741053 |
| 147 | MP0002083_premature_death | 0.60339409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 5.45421220 |
| 2 | Recurrent abscess formation (HP:0002722) | 4.80203694 |
| 3 | Panhypogammaglobulinemia (HP:0003139) | 4.59748786 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 4.35672383 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.08971327 |
| 6 | Agnosia (HP:0010524) | 3.81937317 |
| 7 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.76516798 |
| 8 | Agammaglobulinemia (HP:0004432) | 3.70202367 |
| 9 | Abnormality of macrophages (HP:0004311) | 3.68152267 |
| 10 | Abnormality of the fingertips (HP:0001211) | 3.53315837 |
| 11 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 3.50949478 |
| 12 | Birth length less than 3rd percentile (HP:0003561) | 3.50403174 |
| 13 | Reticulocytopenia (HP:0001896) | 3.43380195 |
| 14 | Degeneration of anterior horn cells (HP:0002398) | 3.37115268 |
| 15 | Abnormality of the anterior horn cell (HP:0006802) | 3.37115268 |
| 16 | Colitis (HP:0002583) | 3.33181191 |
| 17 | Mediastinal lymphadenopathy (HP:0100721) | 3.29230481 |
| 18 | Abnormality of cells of the erythroid lineage (HP:0012130) | 3.16972212 |
| 19 | IgM deficiency (HP:0002850) | 3.16021749 |
| 20 | Selective tooth agenesis (HP:0001592) | 3.12892737 |
| 21 | Abnormal number of erythroid precursors (HP:0012131) | 3.10182537 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.09215472 |
| 23 | Multiple enchondromatosis (HP:0005701) | 3.03397594 |
| 24 | Obstructive lung disease (HP:0006536) | 3.00882852 |
| 25 | Chronic obstructive pulmonary disease (HP:0006510) | 3.00882852 |
| 26 | Rough bone trabeculation (HP:0100670) | 3.00295229 |
| 27 | Oral leukoplakia (HP:0002745) | 2.93173662 |
| 28 | Gastrointestinal inflammation (HP:0004386) | 2.75083193 |
| 29 | Hyperacusis (HP:0010780) | 2.72931980 |
| 30 | Severe combined immunodeficiency (HP:0004430) | 2.71244695 |
| 31 | Spinal muscular atrophy (HP:0007269) | 2.70691490 |
| 32 | Encephalitis (HP:0002383) | 2.68886871 |
| 33 | Breast hypoplasia (HP:0003187) | 2.68447978 |
| 34 | Carpal bone hypoplasia (HP:0001498) | 2.67247642 |
| 35 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.66974507 |
| 36 | Cellulitis (HP:0100658) | 2.66556675 |
| 37 | Meningitis (HP:0001287) | 2.63065968 |
| 38 | Squamous cell carcinoma (HP:0002860) | 2.61055580 |
| 39 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.57110774 |
| 40 | Recurrent viral infections (HP:0004429) | 2.54850145 |
| 41 | Stomatitis (HP:0010280) | 2.53780964 |
| 42 | Inflammation of the large intestine (HP:0002037) | 2.53770104 |
| 43 | Abnormality of DNA repair (HP:0003254) | 2.52872089 |
| 44 | Recurrent skin infections (HP:0001581) | 2.50948656 |
| 45 | Attenuation of retinal blood vessels (HP:0007843) | 2.46413466 |
| 46 | Pustule (HP:0200039) | 2.45983385 |
| 47 | Chromsome breakage (HP:0040012) | 2.45775098 |
| 48 | Impulsivity (HP:0100710) | 2.43865926 |
| 49 | Viral hepatitis (HP:0006562) | 2.43186886 |
| 50 | Gingivitis (HP:0000230) | 2.42964512 |
| 51 | Increased IgE level (HP:0003212) | 2.40680750 |
| 52 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.39991021 |
| 53 | Hypoplasia of the pons (HP:0012110) | 2.39021880 |
| 54 | Thrombocytosis (HP:0001894) | 2.38949048 |
| 55 | Lymphoma (HP:0002665) | 2.38556739 |
| 56 | Patellar aplasia (HP:0006443) | 2.38222409 |
| 57 | Aplastic anemia (HP:0001915) | 2.37885389 |
| 58 | Progressive muscle weakness (HP:0003323) | 2.36941758 |
| 59 | Premature graying of hair (HP:0002216) | 2.36591684 |
| 60 | Pallor (HP:0000980) | 2.34366893 |
| 61 | Cellular immunodeficiency (HP:0005374) | 2.34005269 |
| 62 | Tracheoesophageal fistula (HP:0002575) | 2.32134360 |
| 63 | Trismus (HP:0000211) | 2.31549071 |
| 64 | Clumsiness (HP:0002312) | 2.29801059 |
| 65 | Ependymoma (HP:0002888) | 2.29581214 |
| 66 | Autoimmune thrombocytopenia (HP:0001973) | 2.29346160 |
| 67 | Bone marrow hypocellularity (HP:0005528) | 2.29008056 |
| 68 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.27371658 |
| 69 | Hypochromic anemia (HP:0001931) | 2.27101161 |
| 70 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.25725255 |
| 71 | Macrocytic anemia (HP:0001972) | 2.25221239 |
| 72 | Optic nerve coloboma (HP:0000588) | 2.25204410 |
| 73 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.24103611 |
| 74 | Gastrointestinal infarctions (HP:0005244) | 2.21655143 |
| 75 | Microvesicular hepatic steatosis (HP:0001414) | 2.21241885 |
| 76 | Testicular atrophy (HP:0000029) | 2.16926120 |
| 77 | Acute lymphatic leukemia (HP:0006721) | 2.16613845 |
| 78 | Absent thumb (HP:0009777) | 2.16575433 |
| 79 | Abnormal trabecular bone morphology (HP:0100671) | 2.15047048 |
| 80 | Abnormality of the pons (HP:0007361) | 2.14046115 |
| 81 | Colon cancer (HP:0003003) | 2.12833395 |
| 82 | Rib fusion (HP:0000902) | 2.12756154 |
| 83 | Myelodysplasia (HP:0002863) | 2.12729559 |
| 84 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.12384491 |
| 85 | Personality changes (HP:0000751) | 2.10973662 |
| 86 | Basal cell carcinoma (HP:0002671) | 2.10054340 |
| 87 | Abnormality of T cells (HP:0002843) | 2.09005842 |
| 88 | Combined immunodeficiency (HP:0005387) | 2.08740502 |
| 89 | Chronic hepatic failure (HP:0100626) | 2.08554767 |
| 90 | Interstitial pulmonary disease (HP:0006530) | 2.05231081 |
| 91 | Meckel diverticulum (HP:0002245) | 2.04954735 |
| 92 | Myositis (HP:0100614) | 2.04243265 |
| 93 | Poor head control (HP:0002421) | 2.04228645 |
| 94 | Lymphopenia (HP:0001888) | 2.04084676 |
| 95 | Microretrognathia (HP:0000308) | 2.03919468 |
| 96 | Abnormality of chromosome stability (HP:0003220) | 2.03712051 |
| 97 | Cerebral hypomyelination (HP:0006808) | 2.03254483 |
| 98 | Poikiloderma (HP:0001029) | 2.02243593 |
| 99 | Neoplasm of the pancreas (HP:0002894) | 2.01280448 |
| 100 | Cleft eyelid (HP:0000625) | 1.99554431 |
| 101 | Pointed chin (HP:0000307) | 1.99176869 |
| 102 | Abnormality of the columella (HP:0009929) | 1.98489283 |
| 103 | T lymphocytopenia (HP:0005403) | 1.98378540 |
| 104 | Protruding tongue (HP:0010808) | 1.98195285 |
| 105 | Congenital stationary night blindness (HP:0007642) | 1.97933388 |
| 106 | Abnormality of the preputium (HP:0100587) | 1.97106850 |
| 107 | Hypoplasia of the thymus (HP:0000778) | 1.96558046 |
| 108 | Hypermelanotic macule (HP:0001034) | 1.96230193 |
| 109 | Abnormality of the motor neurons (HP:0002450) | 1.95228894 |
| 110 | Abnormal neuron morphology (HP:0012757) | 1.95228894 |
| 111 | Medulloblastoma (HP:0002885) | 1.95212379 |
| 112 | Abnormality of the ileum (HP:0001549) | 1.94614352 |
| 113 | Abnormality of T cell number (HP:0011839) | 1.94608474 |
| 114 | Osteomyelitis (HP:0002754) | 1.94128828 |
| 115 | Short thumb (HP:0009778) | 1.93738969 |
| 116 | Urticaria (HP:0001025) | 1.93620719 |
| 117 | Abnormal number of incisors (HP:0011064) | 1.93228493 |
| 118 | Abnormality of T cell physiology (HP:0011840) | 1.92993467 |
| 119 | Duplicated collecting system (HP:0000081) | 1.92939553 |
| 120 | Amaurosis fugax (HP:0100576) | 1.92247508 |
| 121 | Albinism (HP:0001022) | 1.91884077 |
| 122 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 1.91033220 |
| 123 | Prominent nose (HP:0000448) | 1.90945382 |
| 124 | Papilloma (HP:0012740) | 1.89638687 |
| 125 | Verrucae (HP:0200043) | 1.89638687 |
| 126 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.89405194 |
| 127 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.88566383 |
| 128 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.87455001 |
| 129 | Leukopenia (HP:0001882) | 1.87388828 |
| 130 | Pancytopenia (HP:0001876) | 1.87328232 |
| 131 | Absent radius (HP:0003974) | 1.87320716 |
| 132 | Annular pancreas (HP:0001734) | 1.87217597 |
| 133 | Tented upper lip vermilion (HP:0010804) | 1.86986371 |
| 134 | Nausea (HP:0002018) | 1.86911255 |
| 135 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 1.86164583 |
| 136 | Genetic anticipation (HP:0003743) | 1.84542333 |
| 137 | Truncal obesity (HP:0001956) | 1.83846448 |
| 138 | Broad distal phalanx of finger (HP:0009836) | 1.83679694 |
| 139 | Periodontitis (HP:0000704) | 1.82865273 |
| 140 | Intestinal fistula (HP:0100819) | 1.81874630 |
| 141 | Deep palmar crease (HP:0006191) | 1.81131999 |
| 142 | Hepatitis (HP:0012115) | 1.80275506 |
| 143 | IgG deficiency (HP:0004315) | 1.80173135 |
| 144 | Aseptic necrosis (HP:0010885) | 1.80046818 |
| 145 | Premature ovarian failure (HP:0008209) | 1.79352928 |
| 146 | Megaloblastic anemia (HP:0001889) | 1.79305417 |
| 147 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.79136175 |
| 148 | Urethral obstruction (HP:0000796) | 1.78684907 |
| 149 | Abnormality of the aortic arch (HP:0012303) | 1.77454880 |
| 150 | Metaphyseal cupping (HP:0003021) | 1.76363886 |
| 151 | Granulocytopenia (HP:0001913) | 1.76250904 |
| 152 | Obsessive-compulsive behavior (HP:0000722) | 1.76210479 |
| 153 | Seborrheic dermatitis (HP:0001051) | 1.76065361 |
| 154 | High pitched voice (HP:0001620) | 1.73943763 |
| 155 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.73107840 |
| 156 | Leukocytosis (HP:0001974) | 1.72299309 |
| 157 | Chronic mucocutaneous candidiasis (HP:0002728) | 1.71065049 |
| 158 | Recurrent cutaneous fungal infections (HP:0011370) | 1.71065049 |
| 159 | Increased cerebral lipofuscin (HP:0011813) | 1.70983197 |
| 160 | Rhabdomyosarcoma (HP:0002859) | 1.70800372 |
| 161 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.67614446 |
| 162 | Gastrointestinal stroma tumor (HP:0100723) | 1.66334776 |
| 163 | Long eyelashes (HP:0000527) | 1.65986123 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BUB1 | 3.82419901 |
| 2 | WEE1 | 3.77544983 |
| 3 | MAP4K1 | 3.30458070 |
| 4 | SIK2 | 3.27199433 |
| 5 | SMG1 | 3.03650157 |
| 6 | CDC7 | 2.85729435 |
| 7 | NME2 | 2.57630682 |
| 8 | EIF2AK1 | 2.49793174 |
| 9 | BLK | 2.41963869 |
| 10 | TSSK6 | 2.10542148 |
| 11 | TESK2 | 2.08035583 |
| 12 | NEK2 | 2.07144949 |
| 13 | EIF2AK3 | 2.07133634 |
| 14 | ICK | 2.03889369 |
| 15 | SIK1 | 2.00579025 |
| 16 | STK10 | 1.95021610 |
| 17 | MAP3K10 | 1.87831460 |
| 18 | PIM2 | 1.83300148 |
| 19 | MAP3K11 | 1.79406601 |
| 20 | MAP3K13 | 1.64238569 |
| 21 | NEK1 | 1.58264111 |
| 22 | WNK4 | 1.55088157 |
| 23 | ZAP70 | 1.52888808 |
| 24 | RPS6KA4 | 1.52234839 |
| 25 | TNK2 | 1.51345036 |
| 26 | KDR | 1.51200318 |
| 27 | PRPF4B | 1.46597677 |
| 28 | FGFR4 | 1.45539349 |
| 29 | SCYL2 | 1.45453908 |
| 30 | BRSK2 | 1.45312227 |
| 31 | TYRO3 | 1.41467871 |
| 32 | MAP3K8 | 1.36842395 |
| 33 | CDK7 | 1.36305689 |
| 34 | MAPK11 | 1.36251310 |
| 35 | PLK1 | 1.35963147 |
| 36 | EPHA2 | 1.33954845 |
| 37 | SRPK1 | 1.32799305 |
| 38 | FES | 1.32689423 |
| 39 | PBK | 1.31749085 |
| 40 | TTK | 1.29620062 |
| 41 | PIM1 | 1.29501588 |
| 42 | ACVR1B | 1.28790394 |
| 43 | MAP2K3 | 1.28129898 |
| 44 | CAMK1D | 1.24386478 |
| 45 | CAMKK1 | 1.22920330 |
| 46 | TYK2 | 1.22560726 |
| 47 | ATR | 1.20463760 |
| 48 | CDK4 | 1.20454022 |
| 49 | LRRK2 | 1.19925332 |
| 50 | ITK | 1.15592742 |
| 51 | ALK | 1.15390522 |
| 52 | IRAK3 | 1.14155567 |
| 53 | BTK | 1.14059645 |
| 54 | MARK2 | 1.13543232 |
| 55 | PAK4 | 1.12907272 |
| 56 | RPS6KB2 | 1.12712682 |
| 57 | IKBKB | 1.11412109 |
| 58 | EEF2K | 1.11391994 |
| 59 | TBK1 | 1.09276821 |
| 60 | AURKB | 1.07723688 |
| 61 | TAOK3 | 1.01859136 |
| 62 | PASK | 1.01764083 |
| 63 | NME1 | 1.00737664 |
| 64 | MAP2K2 | 1.00371399 |
| 65 | TESK1 | 1.00274935 |
| 66 | MAP3K7 | 1.00178390 |
| 67 | CDK12 | 0.99761594 |
| 68 | MAPK15 | 0.97943311 |
| 69 | VRK2 | 0.97669489 |
| 70 | MAP2K6 | 0.96326112 |
| 71 | PLK4 | 0.95513441 |
| 72 | AURKA | 0.95027303 |
| 73 | FLT3 | 0.94510395 |
| 74 | TLK1 | 0.92128347 |
| 75 | ZAK | 0.91948979 |
| 76 | PKN2 | 0.91894398 |
| 77 | BRSK1 | 0.91531357 |
| 78 | HIPK2 | 0.89371113 |
| 79 | MTOR | 0.88505758 |
| 80 | RPS6KA6 | 0.87099748 |
| 81 | MAP3K14 | 0.86624889 |
| 82 | TGFBR1 | 0.85518318 |
| 83 | RIPK4 | 0.85468362 |
| 84 | CDC42BPA | 0.85431795 |
| 85 | GRK6 | 0.85276991 |
| 86 | CSF1R | 0.84477466 |
| 87 | ABL2 | 0.84096083 |
| 88 | KIT | 0.83122731 |
| 89 | JAK3 | 0.81984378 |
| 90 | STK4 | 0.81828265 |
| 91 | VRK1 | 0.80675684 |
| 92 | TRIB3 | 0.80302204 |
| 93 | TXK | 0.79970964 |
| 94 | EIF2AK2 | 0.78507064 |
| 95 | TEC | 0.78449818 |
| 96 | BRD4 | 0.77098794 |
| 97 | RPS6KL1 | 0.76864310 |
| 98 | RPS6KC1 | 0.76864310 |
| 99 | IRAK4 | 0.76572420 |
| 100 | SIK3 | 0.75293373 |
| 101 | CHEK1 | 0.74860599 |
| 102 | PTK6 | 0.74849032 |
| 103 | STK16 | 0.73864496 |
| 104 | TAOK2 | 0.72973466 |
| 105 | SYK | 0.72512795 |
| 106 | MKNK1 | 0.71917305 |
| 107 | CHUK | 0.71821114 |
| 108 | DYRK3 | 0.71458763 |
| 109 | PLK3 | 0.70876191 |
| 110 | CAMK1G | 0.70509052 |
| 111 | MAPK12 | 0.69303936 |
| 112 | MARK3 | 0.69065036 |
| 113 | ERN1 | 0.68819563 |
| 114 | MELK | 0.64640443 |
| 115 | CLK1 | 0.63166959 |
| 116 | CDK8 | 0.62253875 |
| 117 | MAPKAPK3 | 0.62070558 |
| 118 | PRKD2 | 0.61753628 |
| 119 | PAK1 | 0.61013510 |
| 120 | CHEK2 | 0.60090612 |
| 121 | TAOK1 | 0.59826706 |
| 122 | LYN | 0.57470000 |
| 123 | EPHB1 | 0.56459649 |
| 124 | PDK1 | 0.54930704 |
| 125 | DAPK1 | 0.54722359 |
| 126 | CDK2 | 0.54365389 |
| 127 | BMX | 0.54233120 |
| 128 | BRAF | 0.53147868 |
| 129 | CDK6 | 0.52276559 |
| 130 | PDPK1 | 0.52267610 |
| 131 | RPS6KA1 | 0.51807546 |
| 132 | RAF1 | 0.51764845 |
| 133 | RPS6KA5 | 0.51639327 |
| 134 | CSK | 0.50941375 |
| 135 | WNK1 | 0.49204052 |
| 136 | CSNK2A2 | 0.47318318 |
| 137 | TTN | 0.46951015 |
| 138 | PRKCQ | 0.46878047 |
| 139 | IKBKE | 0.46034106 |
| 140 | FGFR3 | 0.45950641 |
| 141 | LCK | 0.45011422 |
| 142 | MAP3K3 | 0.44989910 |
| 143 | CSNK2A1 | 0.44508569 |
| 144 | PRKCI | 0.43692594 |
| 145 | HCK | 0.43521298 |
| 146 | PRKCH | 0.43077367 |
| 147 | PDK2 | 0.42712490 |
| 148 | ATM | 0.42058725 |
| 149 | CAMK4 | 0.39971880 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.38810828 |
| 2 | Mismatch repair_Homo sapiens_hsa03430 | 3.47229071 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.45471703 |
| 4 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 3.25163906 |
| 5 | Base excision repair_Homo sapiens_hsa03410 | 2.91081689 |
| 6 | Ribosome_Homo sapiens_hsa03010 | 2.85614963 |
| 7 | Spliceosome_Homo sapiens_hsa03040 | 2.81227866 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.51671537 |
| 9 | RNA transport_Homo sapiens_hsa03013 | 2.51111751 |
| 10 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.41140162 |
| 11 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.30248491 |
| 12 | Homologous recombination_Homo sapiens_hsa03440 | 2.21822896 |
| 13 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.14183461 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.10060360 |
| 15 | Cell cycle_Homo sapiens_hsa04110 | 1.95687349 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.86116814 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.83730198 |
| 18 | Lysine degradation_Homo sapiens_hsa00310 | 1.70186250 |
| 19 | Leishmaniasis_Homo sapiens_hsa05140 | 1.66554815 |
| 20 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.59843791 |
| 21 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.53997632 |
| 22 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.46612893 |
| 23 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.44903607 |
| 24 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.40047116 |
| 25 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.38331881 |
| 26 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.38276378 |
| 27 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.32273598 |
| 28 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 1.25806011 |
| 29 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.23728045 |
| 30 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.21623396 |
| 31 | RNA degradation_Homo sapiens_hsa03018 | 1.18223652 |
| 32 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.13019652 |
| 33 | Shigellosis_Homo sapiens_hsa05131 | 1.12424030 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.09865751 |
| 35 | Apoptosis_Homo sapiens_hsa04210 | 1.09396056 |
| 36 | ABC transporters_Homo sapiens_hsa02010 | 1.07020137 |
| 37 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.06266479 |
| 38 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.06107371 |
| 39 | Measles_Homo sapiens_hsa05162 | 1.05729040 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.04129227 |
| 41 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.03514423 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.02746039 |
| 43 | Tuberculosis_Homo sapiens_hsa05152 | 1.02121452 |
| 44 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99536150 |
| 45 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.98916196 |
| 46 | Basal transcription factors_Homo sapiens_hsa03022 | 0.98563363 |
| 47 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.96372612 |
| 48 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.94132339 |
| 49 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.94088845 |
| 50 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.91029227 |
| 51 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.86046361 |
| 52 | Influenza A_Homo sapiens_hsa05164 | 0.84083778 |
| 53 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.83374631 |
| 54 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.82476024 |
| 55 | Asthma_Homo sapiens_hsa05310 | 0.81328978 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80992105 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80361758 |
| 58 | Purine metabolism_Homo sapiens_hsa00230 | 0.79728279 |
| 59 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.78810194 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 0.78368874 |
| 61 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.77995883 |
| 62 | Phagosome_Homo sapiens_hsa04145 | 0.76059713 |
| 63 | Hepatitis B_Homo sapiens_hsa05161 | 0.75893980 |
| 64 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.75813154 |
| 65 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.74824515 |
| 66 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.74494695 |
| 67 | HTLV-I infection_Homo sapiens_hsa05166 | 0.74244323 |
| 68 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.73936931 |
| 69 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.73753618 |
| 70 | Allograft rejection_Homo sapiens_hsa05330 | 0.73578384 |
| 71 | Pertussis_Homo sapiens_hsa05133 | 0.73537877 |
| 72 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.71397539 |
| 73 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70726729 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.70147681 |
| 75 | Sulfur relay system_Homo sapiens_hsa04122 | 0.69767942 |
| 76 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69190792 |
| 77 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.68074141 |
| 78 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.67820682 |
| 79 | Salmonella infection_Homo sapiens_hsa05132 | 0.67651207 |
| 80 | Bladder cancer_Homo sapiens_hsa05219 | 0.67631162 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.67127111 |
| 82 | Insulin resistance_Homo sapiens_hsa04931 | 0.65968125 |
| 83 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.65892030 |
| 84 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65738965 |
| 85 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.64167336 |
| 86 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.63531039 |
| 87 | Thyroid cancer_Homo sapiens_hsa05216 | 0.62799059 |
| 88 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.62528061 |
| 89 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.62335536 |
| 90 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61659875 |
| 91 | Malaria_Homo sapiens_hsa05144 | 0.61317057 |
| 92 | Prostate cancer_Homo sapiens_hsa05215 | 0.61247836 |
| 93 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.60537897 |
| 94 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.60512672 |
| 95 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.60046089 |
| 96 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.59283790 |
| 97 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.58675017 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.56044242 |
| 99 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.54025879 |
| 100 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.53859386 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.53760996 |
| 102 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53548646 |
| 103 | Viral myocarditis_Homo sapiens_hsa05416 | 0.51804748 |
| 104 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.51523427 |
| 105 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.51293758 |
| 106 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.49725543 |
| 107 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.48689059 |
| 108 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.47591597 |
| 109 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.47446234 |
| 110 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.46834064 |
| 111 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.46633579 |
| 112 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.46356979 |
| 113 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46099679 |
| 114 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45465135 |
| 115 | Carbon metabolism_Homo sapiens_hsa01200 | 0.45396987 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.45374483 |
| 117 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44510051 |
| 118 | Other glycan degradation_Homo sapiens_hsa00511 | 0.44358029 |
| 119 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.43549482 |
| 120 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43451393 |
| 121 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43222452 |
| 122 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.40475737 |
| 123 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.39862274 |
| 124 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.39738754 |
| 125 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.39151181 |
| 126 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37360780 |
| 127 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.37359751 |
| 128 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.37136414 |
| 129 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.36987715 |
| 130 | Colorectal cancer_Homo sapiens_hsa05210 | 0.36931175 |
| 131 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.36910743 |
| 132 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35605112 |
| 133 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.33808759 |
| 134 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.32467064 |
| 135 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31467676 |
| 136 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.30667609 |

